allergic rhinitis
Conditions
Interventions
Group A:Spleen Aminopeptide Oral Solution
Group B:Spleen Aminopeptide Oral Solution + Loratadine Tablets
Group C:Loratadine Tablets
Sponsors
Affiliated Hospital of Inner Mongolia Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Aged 18 to 65 years male and female; 2. Criteria for the diagnosis of moderate to severe seasonal AR patients: guidelines for the diagnosis and treatment of allergic rhinitis (2015, tianjin) were formulated; 3. Duration of allergic rhinitis >=2 years; 4. patients sign informed consent.
Exclusion criteria
Exclusion criteria: (1) Non-allergic rhinitis with eosinophilia syndrome; (2) Other types of chronic rhinitis; (3) Accompanied by other serious allergic diseases; (4) Patients with serious heart, liver, kidney and brain diseases; (5) Other conditions in which patients are known or suspected to be unable to adhere to the study protocol or the investigator considers inappropriate for inclusion.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Routine blood;Human TH1/TH2 subclass detection;Lymphocyte subsets are absolute; | — |
Countries
China
Contacts
Public ContactCui Xiaobo
Affiliated Hospital of Inner Mongolia Medical University
Outcome results
None listed